A Drug Free, Non-Invasive Approach for Pet Skin Health and Wound Recovery.
VetEase combines VexoHeal, an exosome based serum, with controlled, localized CO₂-powered cooling in a simple, repeatable protocol.
During treatment, VetEase operates at ~2°C to both calm inflammation and discomfort while converting VexoHeal into ultra-fine micro particles (~30 micrometers) that are delivered into the topical skin layers.
The result is a more comfortable, more consistent approach for challenging skin and soft-tissue cases from visit to visit.
Explore the Early Adopter Offer
The VetEase Early Adopter Offer is designed for veterinary hospitals that want to be among the first to bring this technology into practice. In addition to preferred access, early adopter hospitals receive launch support, discounted economics, and tools to help build awareness and adoption within the clinic.
Complete the form, and a member of our team will reach out with more information.
Early Adopters Receive:
Preferred device pricing - Receive an early adopter discount on the VetEase device as part of this limited launch offer.
On-site founder-led onboarding - Get on-site onboarding led by the founder to help your team start strong with training, workflow integration, and implementation support.
Lifetime discount on consumables - Early adopter hospitals receive a lifetime discount on consumables, creating a more attractive long-term economic model as usage grows.
Publication and professional visibility opportunities - Participating hospitals may have the opportunity to be featured in case documentation, publications, and professional visibility initiatives related to VetEase adoption and clinical experience.
Client-facing clinic marketing brochure - The offer includes a client facing tri-fold brochure that your hospital can use to introduce VetEase to pet owners and support in-clinic marketing.